HCW Biologics News - August 2026
🟢 HCW Biologics is trading 15.63% up in pre-market — no clear catalyst identified
HCW Biologics is trading 15.63% up at $2.46 after no clear August 19, 2026 company-specific catalyst was identified. - The latest major disclosure was the...
HCW Biologics Posts Widening Losses and Going-Concern Warning — Can This Biotech Survive Long Enough to Prove Its Science?
Shares of HCW Biologics plunged nearly 28% over the past week, falling from $3.17 to $2.28, after the clinical-stage biotech disclosed second-quarter results...
🔴 HCW Biologics is trading 9.69% down in pre-market after wider losses and going-concern doubt
HCW Biologics is trading 9.69% down at $2.28 after its August 14, 2026, second-quarter report highlighted a wider net loss and substantial doubt about...
🔴 HCW Biologics is trading 5.78% down today after going-concern warning
HCW Biologics is trading 5.78% down now at $2.52 after investors continued reacting to the August 14, 2026 earnings release. - Second-quarter net loss widened...
HCW Biologics Inc Q2 2026 Earnings Preview: What Analysts Expect on August 17, 2026
Wall Street analysts expect HCW Biologics to report a net loss of $1.98 per share for the second quarter of 2026, while the stock currently trades at...
HCW Biologics second quarter 2026 loss hit $5.2M despite $6.7M year-to-date licensing revenue
HCW Biologics reported second quarter 2026 revenue of $0.14 million and a net loss of $5.2 million. While year-to-date performance was bolstered by a...
🟢 HCW Biologics is trading 19.66% up in pre-market — no confirmed catalyst identified
HCW Biologics is trading 19.66% up at $3.50 in pre-market, with no confirmed company-specific catalyst identified for August 14. - The stock fell 7.00% to...
🟢 HCW Biologics is trading 5.3% up today on continued insider-buying momentum
HCW Biologics is trading at $3.79 (5.3% up) in pre-market, extending a strong multi-day rally that began in late July. • Recent gains are driven by sustained...
🟢 HCW Biologics is trading 24% up today after CEO Hing Wong discloses share purchase
HCW Biologics is trading at $3.96 (23.8% up) today after an SEC filing revealed that CEO and 10% owner Hing Wong purchased 23,210 shares at $2.59 on July 29,...